General Information of the Compound
Compound ID
CP0305129
Compound Name
2-[(2R)-4-(4-fluoro-3-methylsulfonylphenyl)-2-propan-2-ylpiperazin-1-yl]-4-(trifluoromethyl)pyrimidine
    Show/Hide
Synonyms
BDBM50177012
CHEMBL3814153
SCHEMBL17519222
    Show/Hide
Structure
Formula
C19H22F4N4O2S
Molecular Weight
446.47
Canonical SMILES
CC(C)[C@@H]1CN(CCN1c1nccc(n1)C(F)(F)F)c1ccc(F)c(c1)S(C)(=O)=O
    Show/Hide
InChI
InChI=1S/C19H22F4N4O2S/c1-12(2)15-11-26(13-4-5-14(20)16(10-13)30(3,28)29)8-9-27(15)18-24-7-6-17(25-18)19(21,22)23/h4-7,10,12,15H,8-9,11H2,1-3H3/t15-/m0/s1
    Show/Hide
InChIKey
YTEDTWJJQBCOTI-HNNXBMFYSA-N
Physicochemical Property
logP
3.3892
Rotatable Bonds
4
Heavy Atom Count
30
Polar Areas
66.4
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
6
Complexity
30

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 118883427
ChEMBL ID
CHEMBL3814153
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01555, Oxysterols receptor LXR-alpha
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
EC50 = 254 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 Ki = 25 nM
Protein ID: PT01887, Oxysterols receptor LXR-beta
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
EC50 = 53 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 Ki = 1 nM
Clinical Information about the Compound
Drug 1 ( BDBM50177012 )
Drug Name BDBM50177012
Target(s)
Oxysterols receptor LXR-alpha (NR1H3)
Inhibitor